TrivarX Limited (MDBIF)

OTCMKTS · Delayed Price · Currency is USD

0.0095

+0.0046 (93.88%)

At close: Sep 23, 2026

Market Cap	8.91M +98.3%
Revenue (ttm)	10.08K -98.6%
Net Income	-6.06M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,036
Open	0.00695
Previous Close	0.0049
Day's Range	0.00695 - 0.0095
52-Week Range	0.0025 - 0.0278
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 1987

Employees 6

Stock Exchange OTCMKTS

Ticker Symbol MDBIF

Financial Performance

In fiscal year 2026, TrivarX's revenue was 14,566, a decrease of -98.59% compared to the previous year's 1.03 million. Losses were -8.76 million, 829.0% more than in 2025.

Financial numbers in AUD Financial Statements